Irbesartan vs Sitagliptin
Irbesartan vs Sitagliptin: Overview
This comparison examines the pharmacological differences between Irbesartan and Sitagliptin.
Mechanism of Action
Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.
Sitagliptin: DPP-4 inhibitor increasing incretin levels.
Pharmacokinetics
Half-life: Irbesartan β 11-15 hours; Sitagliptin β 12.4 hours.
Chemical Properties
Molecular Formula: Irbesartan β C25H28N6O; Sitagliptin β C16H15F6N5O.
Molecular Weight: Irbesartan β 428.5320 g/mol; Sitagliptin β 407.3140 g/mol.
Type: Irbesartan β Small molecule; Sitagliptin β Small molecule.